Zetia: Effective Cholesterol Management for Better Cardiovascular Health
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.71 | $51.30 (0%) | 🛒 Add to cart |
| 60 | $1.37 | $102.61 $82.49 (20%) | 🛒 Add to cart |
| 90 | $1.26 | $153.91 $113.67 (26%) | 🛒 Add to cart |
| 120 | $1.22 | $205.21 $145.86 (29%) | 🛒 Add to cart |
| 180 | $1.16 | $307.82 $208.23 (32%) | 🛒 Add to cart |
| 270 | $1.12 | $461.73 $302.79 (34%) | 🛒 Add to cart |
| 360 | $1.10
Best per pill | $615.63 $396.34 (36%) | 🛒 Add to cart |
Synonyms | |||
Zetia (ezetimibe) is a prescription medication specifically designed to lower elevated levels of low-density lipoprotein (LDL) cholesterol, commonly known as ‘bad’ cholesterol, in the blood. It operates through a unique mechanism of action, distinct from statins, by selectively inhibiting the absorption of cholesterol in the small intestine. This targeted approach makes it a valuable option either as monotherapy or in combination with other lipid-lowering agents for patients who require additional cholesterol control. By effectively reducing LDL cholesterol, Zetia contributes to a decreased risk of atherosclerosis and associated cardiovascular events, supporting long-term heart health under proper medical supervision.
Features
- Active ingredient: Ezetimibe 10mg per tablet
- Unique mechanism: Selectively inhibits intestinal cholesterol absorption
- Administration: Oral tablet, taken once daily
- Compatibility: Can be used alone or co-administered with statins
- Prescription status: Available only with a valid physician’s prescription
- Manufacturing: Produced under strict pharmaceutical quality standards
Benefits
- Significantly reduces LDL cholesterol levels through targeted action
- Lowers total cholesterol and non-HDL cholesterol concentrations
- Decreases absorption of dietary cholesterol without affecting fat-soluble vitamins
- Provides complementary cholesterol management when used with statins
- Offers an alternative for patients intolerant to statin therapy
- Contributes to reduced risk of cardiovascular events with long-term use
Common use
Zetia is primarily prescribed for the treatment of primary hyperlipidemia, either as monotherapy or in combination with HMG-CoA reductase inhibitors (statins). It is indicated for patients who require additional LDL cholesterol reduction beyond what can be achieved through diet and exercise alone. The medication is also used in cases of homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatments. Physicians may prescribe Zetia for patients who are intolerant to statins or who require combination therapy to reach target cholesterol levels as established by current cardiovascular guidelines.
Dosage and direction
The recommended dosage of Zetia is 10mg taken orally once daily, with or without food. When used in combination with a statin, both medications may be taken simultaneously. For patients also taking bile acid sequestrants, Zetia should be taken at least 2 hours before or 4 hours after the bile acid sequestrant. Dosage adjustments are not typically required for elderly patients or those with mild hepatic impairment. Patients should follow their physician’s specific instructions regarding timing and administration, and continue taking Zetia even if they feel well, as high cholesterol typically has no symptoms.
Precautions
Patients should inform their healthcare provider of any history of liver disease or abnormal liver function tests before starting Zetia. Regular monitoring of liver enzymes is recommended, particularly when used in combination with statins. The medication should be used with caution in patients taking cyclosporine due to increased blood levels of both drugs. Patients should maintain their cholesterol-lowering diet during treatment. Women who are pregnant or planning to become pregnant should discuss the risks and benefits with their physician, as cholesterol is essential for fetal development.
Contraindications
Zetia is contraindicated in patients with known hypersensitivity to ezetimibe or any component of the formulation. The medication should not be used in patients with active liver disease or unexplained persistent elevations in serum transaminases. Concomitant use with statins is contraindicated in patients with active liver disease or persistent elevations of hepatic transaminases. The combination therapy is also contraindicated during pregnancy and breastfeeding due to potential risk to the fetus or infant.
Possible side effects
Common side effects may include headache, diarrhea, upper respiratory tract infection, muscle pain, and joint pain. Less frequently reported side effects include fatigue, abdominal pain, back pain, and sinusitis. Rare but serious side effects may include allergic reactions (rash, hives, swelling), liver problems (unusual fatigue, loss of appetite, dark urine), and muscle problems (unexplained muscle pain, tenderness, or weakness). Patients should report any persistent or severe side effects to their healthcare provider promptly.
Drug interaction
Zetia may interact with several medications including cyclosporine (increases ezetimibe levels), fibrates (may increase risk of cholelithiasis), and warfarin (may require monitoring of INR). Bile acid sequestrants such as cholestyramine decrease the absorption of ezetimibe. When used with statins, the risk of myopathy may be increased. Patients should inform their physician of all medications they are taking, including prescription drugs, over-the-counter medications, and herbal supplements.
Missed dose
If a dose of Zetia is missed, patients should take it as soon as they remember, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Patients should not take a double dose to make up for a missed one. Consistency in taking Zetia is important for maintaining stable cholesterol levels, so establishing a routine for daily administration is recommended.
Overdose
In case of suspected overdose, patients should seek immediate medical attention or contact a poison control center. Symptoms of overdose may include gastrointestinal discomfort. There is no specific antidote for ezetimibe overdose, and treatment should be symptomatic and supportive. Hemodialysis is not expected to significantly enhance elimination of ezetimibe due to its extensive protein binding. Patients should always store medications out of reach of children to prevent accidental ingestion.
Storage
Zetia tablets should be stored at room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be kept in its original container with the lid tightly closed to protect from moisture and light. Tablets should not be stored in bathroom cabinets where humidity levels fluctuate. Keep all medications out of reach of children and pets. Properly discard any expired or unused medication according to local guidelines.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Zetia is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Individual results may vary, and not all patients will experience the same benefits or side effects. Patients should not discontinue or change their dosage without consulting their physician. The information provided here is not exhaustive, and patients should refer to the official prescribing information for complete details.
Reviews
Clinical studies have demonstrated that Zetia significantly reduces LDL cholesterol levels by approximately 18-20% when used as monotherapy, and provides additional LDL reduction of 25% or more when combined with statins. Many patients report satisfactory cholesterol management with good tolerability. Some patients who were unable to tolerate higher doses of statins have found Zetia alone or in combination with lower statin doses to be an effective alternative. Healthcare providers generally consider Zetia a valuable addition to the arsenal of cholesterol-lowering medications, particularly for patients who need additional LDL reduction beyond what statins can provide alone.